Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Relapsed or Refractory Acute Myeloid Leukemia
100%
Bortezomib
100%
Guillain-Barré Syndrome
100%
Clinical Examination
25%
High Risk
25%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
25%
Chemotherapy Regimen
25%
Magnetic Resonance Imaging
25%
Young Males
25%
12-year-olds
25%
Serum Immunoglobulins
25%
Numbness
25%
Clinical Recovery
25%
Inflammatory Demyelinating Polyneuropathy
25%
Cerebrospinal Fluid Analysis
25%
Electrodiagnosis
25%
Anti-gangliosides
25%
Intravenous Immunoglobulin (IVIg)
25%
Progressive Weakness
25%
Intravenous Immunoglobulin Therapy
25%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Bortezomib
100%
Immunoglobulin
50%
Clinical Examination
25%
Magnetic Resonance Imaging
25%
Chemotherapy Regimens
25%
Leg
25%
Ganglioside
25%
Polyneuropathy
25%
Weakness
25%
Electrodiagnosis
25%
Paresthesia
25%
Immunoglobulin Antibody
25%
Cerebrospinal Fluid Analysis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Syndrome
100%
Bortezomib
100%
Immunoglobulin
50%
Chemotherapy Regimens
25%
Ganglioside
25%
Polyneuropathy
25%
Weakness
25%
Paresthesia
25%
Immunoglobulin Antibody
25%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Magnetic Resonance Imaging
50%
Cerebrospinal Fluid
50%
Leg
50%
Immunoglobulin Blood Level
50%
Immunoglobulin Antibody
50%
Neuroscience
Bortezomib
100%
Intravenous Immunoglobulin
50%
Magnetic Resonance Imaging
25%
Chemotherapy Regimens
25%
Electrodiagnosis
25%
Polyneuropathy
25%
Ganglioside
25%
Immunoglobulin Antibody
25%